Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29212727 | 0.93 | AHR (0.54) | AHR | |
| SCHEMBL30525702 | 0.84 | TSHR (0.44) | AHR | |
| SCHEMBL30786817 | 0.80 | — | — | |
| SCHEMBL28840933 | 0.80 | — | — | |
| SCHEMBL5795441 | 0.75 | AHR (0.50) | AHR | |
| SCHEMBL15666282 | 0.75 | AHR (0.36) | AHR | |
| SCHEMBL29712922 | 0.75 | AHR (0.36) | AHR | |
| SCHEMBL9393907 | 0.72 | MCHR1 (0.46) | — | |
| SCHEMBL11765400 | 0.72 | AHR (0.34) | AHR | |
| SCHEMBL30493572 | 0.69 | AHR (0.48) | AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020035278-A1 | Methods for synthesis of substituted tetrahydrofuran compound | MILLENNIUM PHARMACEUTICALS, INC. | 2002-03-21 | — | — | US | claimed |
| US-6310221-B1 | PREPARING A 4-FLUOROPHENOXYMETHYL-(HYDROXY)-TETRAHYDROFURAN BY REACTING 4-FLUOROPHENOL AND AN EPOXY COMPOUND; REACTING THE EPOXY-PHENYL ETHER WITH AN ACTIVE METHYLENE COMPOUND TO FORM A LACTONE; AND REDUCING THE LACTONE | MILLENNIUM PHARMACEUTICALS, INC. | 2001-10-30 | — | — | US | claimed |
| CN-1313857-A | Process for the synthesis of substituted tetrahydrofuran compounds | LEUKOSITE INC (US) | 2001-09-19 | — | — | CN | claimed |
| EP-1102759-A1 | METHODS FOR SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN COMPOUND | Millennium Pharmaceuticals, Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| WO-2000001683-A1 | METHODS FOR SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN COMPOUND | LEUKOSITE, INC. (US) | 2000-01-13 | — | — | WO | claimed |
| CN-115718406-A | Photosensitive resin composition for forming resist, resin film, cured film, and semiconductor device | 住友电木株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-20120108784-A1 | HIGHLY-BRANCHED OR HYPER-BRANCHED POLYESTER AND THE PRODUCTION AND APPLICATION THEREOF | BASF SE (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20100048813-A1 | HIGHLY-BRANCHED OR HYPER-BRANCHED POLYESTER AND THE PRODUCTION AND APPLICATION THEREOF | BASF SE (DE) | 2010-02-25 | — | — | US | disclosed |
| CN-101583650-A | Highly-branched or hyper-branched polyester and the production and application thereof | BASF SE (DE) | 2009-11-18 | — | — | CN | disclosed |
| EP-2091995-A1 | HIGHLY-BRANCHED OR HYPER-BRANCHED POLYESTER AND THE PRODUCTION AND APPLICATION THEREOF | BASF SE (DE) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008058886-A1 | HIGHLY-BRANCHED OR HYPER-BRANCHED POLYESTER AND THE PRODUCTION AND APPLICATION THEREOF | BASF SE (DE) | 2008-05-22 | — | — | WO | disclosed |
| WO-2007125029-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYESTERS WITH A LOW ACID NUMBER AND PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-08 | — | — | WO | disclosed |
| WO-2006084880-A1 | METHOD FOR PRODUCING OLIGOMERISED POLYISOCYANATES AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-17 | — | — | WO | disclosed |
| WO-2004076738-A1 | LEVELLING AGENT FOR DYEING FIBRES | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-10 | — | — | WO | disclosed |
| WO-2004054958-A1 | HYDROXYALKYLATION METHOD | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035278-A1 | Methods for synthesis of substituted tetrahydrofuran compound | DHFR, CYP3A4, CYP3A5 | AHR 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.